2536. Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides and aztreonam/avibactam against 8 VIM-producing CRE

BACKGROUND: Treatment of infections caused by CRE often involves beta-lactam-containing combination therapy, either with a beta-lactamase inhibitor or an agent from a different antimicrobial class. We sought to investigate the activity of several beta-lactam combinations against 8 VIM-producing CRE...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Justin A, Burgess, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679082/
http://dx.doi.org/10.1093/ofid/ofad500.2153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679082/
http://dx.doi.org/10.1093/ofid/ofad500.2153

Ejemplares similares